ARTICLES BY SHANKER OJHA
-
![nurse scanning barcode-GettyImages-618647626]( "What Advanced Therapy Logistics Actually Need From Patient-Specific Supply Models")
7/13/2026Advanced therapies demand patient-specific logistics with zero margin for error. Learn how digital traceability, agile supply models, and culture protect every dose.
-
![real-time analytics-GettyImages-2199034104]( "AI And Predictive Analytics For Clinical Supply Planning")
7/7/2026AI-driven predictive analytics can cut drug waste, improve forecasting accuracy, and optimize clinical supply while maintaining service levels and regulatory compliance.
-
![compliance, quality assurance, certification-GettyImages-1357020474]( "What Clinical Trial Supply Teams Actually Need From CQV Before Batch Release")
6/15/2026Batch release delays rarely start in QA. Learn how CQV, digital integrity, risk-based validation, and global compliance keep clinical supplies moving.
Shanker Ojha
Shanker Ojha is a biopharmaceutical validation professional with over a decade of hands-on experience managing complex commissioning, qualification, and validation (CQV) cycles, QMS, and GMP compliance. His career is built on the shop floor, bridging the gap between technical engineering and time-sensitive manufacturing operations, including leading major process validation projects for biologics.
Having worked directly inside manufacturing hubs, Ojha knows firsthand how clinical supply lines stall when validation is treated as a retrospective paperwork drill. His focus is on synchronizing computer system validation (CSV) with physical assets and using risk-based frameworks to compress timelines. Shanker advocates for floor-level psychological safety, ensuring operators can flag technical anomalies instantly to resolve issues in real time.